Basis: FMP quote market capitalization / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
The Price/FCF ratio is N/A as of 2026-10-06T19:42:27.290Z.
Calculation as of: 2026-10-06T19:42:27.290Z.
Quote observation: 2026-10-06T19:40:19.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 347a41eedf46a91d1f1a35dde2c997a021a555167078676fef94c90a8032fb0d
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PRICE/FCF RATIO
N/A
MiniMed Group, Inc. Common Stock
Market Cap
$5.48B
Price/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.29B
Price/FCF Ratio
N/A
TTM Avg
10.35
3Y Avg
10.35
5Y Avg
10.35
Market Cap
$5.22B
Price/FCF Ratio
N/A
TTM Avg
13.18
3Y Avg
68.65
5Y Avg
68.65
Market Cap
$5.21B
Price/FCF Ratio
101.19
TTM Avg
288.32
3Y Avg
288.32
5Y Avg
288.32
Market Cap
$5.20B
Price/FCF Ratio
46.10
TTM Avg
47.00
3Y Avg
56.70
5Y Avg
49.92
Market Cap
$5.82B
Price/FCF Ratio
N/A
TTM Avg
1.10
3Y Avg
1.10
5Y Avg
1.10
| NAME | MARKET CAP | PRICE/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| MiniMed Group, Inc. Common Stock (MMED) | $5.48B | N/A | N/A | N/A | N/A |
| RadNet, Inc. (RDNT)vs › | $5.51B | N/A | 80.60 | 77.93 | 72.44 |
| CG Oncology Inc. (CGON)vs › | $5.59B | N/A | N/A | N/A | N/A |
| PTC Therapeutics, Inc. (PTCT)vs › | $5.29B | N/A | 10.35 | 10.35 | 10.35 |
| Doximity, Inc. (DOCS)vs › | $5.22B | 17.43 | 21.47 | 35.28 | 47.18 |
| CRISPR Therapeutics AG (CRSP)vs › | $5.22B | N/A | 13.18 | 68.65 | 68.65 |
| Travere Therapeutics, Inc. (TVTX)vs › | $5.21B | 101.19 | 288.32 | 288.32 | 288.32 |
| Sotera Health Company (SHC)vs › | $5.20B | 46.10 | 47.00 | 56.70 | 49.92 |
| Iovance Biotherapeutics, Inc. (IOVA)vs › | $5.82B | N/A | 1.10 | 1.10 | 1.10 |
| Kodiak Sciences Inc. (KOD)vs › | $5.82B | N/A | N/A | N/A | N/A |
P/FCF Ratio
N/A
FCF Yield
N/A
P/FCF measures market price relative to free cash flow per share. Free cash flow is operating cash flow after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
